Erste Group Downgrades GE Vernova to Hold From Buy
Erste Group Bank AG has downgraded its rating for GE Vernova Inc. from Buy to Hold.
Stocks · News reference
Emergent BioSolutions has entered into a partnership with Asimov to develop cell lines for two monoclonal antibodies targeting Ebola.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Erste Group Bank AG has downgraded its rating for GE Vernova Inc. from Buy to Hold.
Analysts from Erste Group Research issued a positive assessment regarding Mayr-Melnhof Karton's agreement to sell 70 percent of its packaging business to KPS Capital Partners.
Emergent BioSolutions announced that members of its senior management team will participate in the upcoming Jefferies Global Healthcare Conference in London.
Erste Group Bank AG has been mandated as a Joint Lead-Manager to organize fixed-income meetings for a potential issuance of Additional Tier 1 subordinated notes by Nova Ljubljanska banka d.d.
Erste Group Bank AG and its subsidiary Erste Bank Polska S.A. have announced a joint investment in the Innovate PL FoF program to support private equity, private debt, and venture capital funds.
Emergent BioSolutions has secured a contract modification from the U.S. Department of Defense valued at up to $22.3 million to supply its BioThrax vaccine.